HDM-2022

N/A

Report date: 2026/01/30 18:00:10
NME

Base Information

Drug NameHDM-2022
Drug Alias NameHDM-2022HDM2022
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuadong Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A